title: Probabilistic drug connectivity mapping.
abstract: BACKGROUND
  The aim of connectivity mapping is to match drugs using drug-treatment gene expression profiles from multiple cell lines. This can be viewed as an information retrieval task, with the goal of finding the most relevant profiles for a given query drug. We infer the relevance for retrieval by data-driven probabilistic modeling of the drug responses, resulting in probabilistic connectivity mapping, and further consider the available cell lines as different data sources. We use a special type of probabilistic model to separate what is shared and specific between the sources, in contrast to earlier connectivity mapping methods that have intentionally aggregated all available data, neglecting information about the differences between the cell lines.
  
  
  RESULTS
  We show that the probabilistic multi-source connectivity mapping method is superior to alternatives in finding functionally and chemically similar drugs from the Connectivity Map data set. We also demonstrate that an extension of the method is capable of retrieving combinations of drugs that match different relevant parts of the query drug response profile.
  
  
  CONCLUSIONS
  The probabilistic modeling-based connectivity mapping method provides a promising alternative to earlier methods. Principled integration of data from different cell lines helps to identify relevant responses for specific drug repositioning applications.
authors.forename: Juuso A
authors.initials: JA
authors.lastname: Parkkinen
authors.affiliation: Helsinki Institute for Information Technology HIIT, Department of Information and Computer Science, Aalto University, Espoo, Finland. samuel.kaski@aalto.fi.
authors.forename: Samuel
authors.initials: S
authors.lastname: Kaski
mesh_terms: D002460:Cell Line; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D020869:Gene Expression Profiling; D006801:Humans; D015233:Models, Statistical; D059467:Transcriptome / Q000187:drug effects*
references.citation: BMC Bioinformatics. 2013 Aug 12;14:245
references.pmid: 23937249
references.citation: BMC Bioinformatics. 2012 May 30;13:112
references.pmid: 22646858
references.citation: Blood. 2010 Dec 23;116(26):5983-90
references.pmid: 20889920
references.citation: Drug Discov Today. 2012 Dec;17(23-24):1289-98
references.pmid: 22889966
references.citation: Nat Rev Drug Discov. 2009 Feb;8(2):111-28
references.pmid: 19180105
references.citation: Bioinformatics. 2010 Jun 15;26(12):i391-8
references.pmid: 20529933
references.citation: PLoS Comput Biol. 2010 Sep 09;6(9):
references.pmid: 20838579
references.citation: Nat Biotechnol. 2012 Jul 10;30(7):679-92
references.pmid: 22781697
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
references.pmid: 16199517
references.citation: Drug Discov Today. 2013 Apr;18(7-8):350-7
references.pmid: 22897878
references.citation: Science. 2006 Sep 29;313(5795):1929-35
references.pmid: 17008526
references.citation: Curr Opin Struct Biol. 2006 Feb;16(1):127-36
references.pmid: 16442279
references.citation: Nature. 2009 Nov 12;462(7270):175-81
references.pmid: 19881490
references.citation: Mol Syst Biol. 2013;9:662
references.pmid: 23632384
references.citation: Nucleic Acids Res. 2003 Feb 15;31(4):e15
references.pmid: 12582260
references.citation: J Comput Biol. 2011 Mar;18(3):251-61
references.pmid: 21385032
references.citation: Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14621-6
references.pmid: 20679242